A phase II study of paclitaxel, carboplatin, and gemcitabine in previously untreated patients with epithelial ovarian cancer FIGO stage IC–IV (AGO-OVAR protocol OVAR-8)
- 18 February 2005
- journal article
- clinical trial
- Published by Elsevier in Gynecologic Oncology
- Vol. 96 (2) , 444-451
- https://doi.org/10.1016/j.ygyno.2004.10.020
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Pilot study of outpatient paclitaxel, carboplatin and gemcitabine for advanced stage epithelial ovarian, peritoneal, and fallopian tube cancerGynecologic Oncology, 2004
- Phase I feasibility trial of carboplatin, paclitaxel, and gemcitabine in patients with previously untreated epithelial ovarian or primary peritoneal cancer: a Gynecologic Oncology Group studyGynecologic Oncology, 2004
- Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group StudyJournal of Clinical Oncology, 2003
- Randomized Intergroup Trial of Cisplatin-Paclitaxel Versus Cisplatin-Cyclophosphamide in Women With Advanced Epithelial Ovarian Cancer: Three-Year ResultsJNCI Journal of the National Cancer Institute, 2000
- Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian CancerNew England Journal of Medicine, 1996
- Phase II Study of Gemcitabine (2',2'-Difluorodeoxycytidine) in Previously Treated Ovarian Cancer PatientsJNCI Journal of the National Cancer Institute, 1994
- Comparison of the Emetogenic Potential Between Cisplatin and Carboplatin in Combination with Alkylating AgentsActa Oncologica, 1994
- A Comparison of the Toxicity and Efficacy of Cisplatin and Carboplatin in Advanced Ovarian CancerActa Oncologica, 1989
- Promotion of microtubule assembly in vitro by taxolNature, 1979
- Creatinine Clearance: Bedside EstimateAnnals of Internal Medicine, 1973